Cohance Lifesciences has appointed Sunil Kumar Singh as its Chief Quality Officer, effective January 19, 2026. Mr. Singh brings over 35 years of experience in pharmaceutical quality across various sectors, including APIs, formulations, and CDMO. His previous role was as Global Head – Quality for the PSAI Business at Dr. Reddy’s Laboratories. He holds a Master’s degree in Management and a B.Sc. (Tech) in Pharmaceuticals.
Appointment of Chief Quality Officer
Cohance Lifesciences announced the appointment of Sunil Kumar Singh as Chief Quality Officer, effective January 19, 2026. The decision was made based on recommendations from the Nomination and Remuneration Committee.
Experience and Expertise
Mr. Singh brings over 35 years of leadership experience in pharmaceutical quality, spanning APIs, formulations, CDMO, and external manufacturing. He previously served as Global Head – Quality for the PSAI Business at Dr. Reddy’s Laboratories.
Mr. Singh’s Background
Mr. Singh’s background includes extensive experience in building quality organizations and driving business growth. He has worked with multinational companies including Mylan, Zydus, Glenmark, and Cipla.
He holds a Master’s degree in Management and a B.Sc. (Tech) in Pharmaceuticals and Fine Chemicals.
Source: BSE
